FDA to release notification rule to curb drug shortages

06/20/2013 | Health Data Management

Drugmakers will have to notify the FDA about interruptions or discontinuances in the manufacturing of life-saving treatments under a proposed rule, which the agency is set to publish. The rule would mandate early notification from makers of drugs considered life-sustaining, life-supporting or used in the treatment or prevention of debilitating diseases.

View Full Article in:

Health Data Management

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
CareFusion
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ